On September 15, CAR-T cell company Legend Biotech announced that the board of directors has appointed Zhang Ying as CEO, effective September 15, 2026. Prior to joining Legendary Biotech, Zhang Ying was the Chief Commercial Officer of Novartis International Business. During her tenure at Novartis, she also served as President of Novartis Innovative Pharmaceuticals China and President of Novartis China.
智通财经·09/15/2026 12:49:06
语音播报
On September 15, CAR-T cell company Legend Biotech announced that the board of directors has appointed Zhang Ying as CEO, effective September 15, 2026. Prior to joining Legendary Biotech, Zhang Ying was the Chief Commercial Officer of Novartis International Business. During her tenure at Novartis, she also served as President of Novartis Innovative Pharmaceuticals China and President of Novartis China.